Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis — Stella

Home/Chronic Kidney Diseases/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Kidney Diseases trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

China

The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu

Key details

Phase

Very early testing

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

Westlake University

Enrollment target

~9 participants

Started

September 2018

Primary completion

September 2027

Age range

18 Years – 75 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.